SEC Tracker
Get the app

SAB Biotherapeutics SABS

SAB Biotherapeutics: signs a material agreement, completes an acquisition or sale of assets and 6 other items

Form
8-K
Filed
Importance
Routine
  • Signs a material agreement (1.01)
  • Completes an acquisition or sale of assets (2.01)
  • Sells unregistered shares (3.02)
  • Changes its auditor (4.01)
  • Reports a change in control (5.01)
  • Reports an executive or board change (5.02)
  • Amends its charter or bylaws (5.03)
  • Changes its shell company status (5.06)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when SAB Biotherapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. XBiotech XBIT public float $77M, Jun 30, 2025
  2. Oramed Pharmaceuticals ORMP public float $78M, Jun 30, 2025
  3. Inovio Pharmaceuticals INO public float $74M, Jun 30, 2025
  4. Macrogenics MGNX public float $74M, Jun 30, 2025
  5. Volitionrx VNRX public float $73M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.